Product
RPL554
Aliases
Part A: RPL554, Part B: RPL554
3 clinical trials
4 indications
Indication
Pulmonary DiseaseIndication
Chronic ObstructiveIndication
Chronic Obstructive Pulmonary DiseaseIndication
Cystic FibrosisClinical trial
A Phase II, Randomized Study to Assess the Pharmacokinetics, Safety and Pharmacodynamics of Single and Repeat Doses of RPL554 Administered by Dry Powdered Inhaler in Patients With COPDStatus: Completed, Estimated PCD: 2019-05-23
Clinical trial
A Phase II, Randomised Study to Assess the Pharmacokinetics, Safety and Pharmacodynamics of Single and Repeat Doses of RPL554 Administered by Pressurised Metered Dose Inhaler in Patients With COPDStatus: Completed, Estimated PCD: 2020-12-10
Clinical trial
A Phase IIa, Randomised, Double Blind, Placebo Controlled, Three Way Crossover Study to Assess the Pharmacokinetics of RPL554 Administered to Adult Patients With Cystic Fibrosis.Status: Completed, Estimated PCD: 2017-11-03